Objective: This research is designed to explore the methods of isolation and culture for endothelial progenitor cells from bovine bone marrow, characteristic, induced differentiative capacity in vitro. Material and methods: Main experimental reagents contain DMEM/F12, fetal bovine serum, percoll lymphocyte separating, Trypsin 1: 250, VEGF, bFGF, GF-1, EDTA and so on. Cultivation system is DMEM/F12 with 10% FBS and VEGF 10 ng/mL, cultured under 37°C, 5% CO2, saturated humidity. Cell viability is measured by trypan blue solution exclusion test. Immunofluorescent detection is used to detected cell surface markers and double swallows, while bovine chromosome is analyzed by karyotyping. Results: We find that the majority of bovine endothelial progenitor cells (EPCs) are fibrous shaped. Frozen survival of bovine EPCs before and after cryopreservation is 95.2±0.14% and 80.9±0.30% respectively; cryopreservation affects little on the viability of bovine EPCs. Immunofluorescent detection of the cell surface markers CD34, CD133 and flk present positive, which can confirm that the cell cultured in vitro are EPCs. Then Dil-ac-LDL and FITC-UAE-1 uptake assays are carried out. Eventually, bovine EPCs are induced to differentiate into endothelial cells and smooth muscle cells respectively, demonstrating the multi-lineage differentiation potential of bovine EPCs in vitro. Conclusion: EPCs can be got with proper culture system. The little cell cryopreservation effect and stronger induced differentiation potential in vitro imply that EPCs can be applied in genetic resources conservation and reuse.
INTRODUCTION
Endothelial progenitor cells (EPCs) are also known as precursor cells used in the treatment of atherosclerosis, which can differentiate into mature endothelial cells that participate in the repair of endothelial injury (Talbot and Blombergie, 2008; Spadaccio et al., 2010) . In recent years, EPC transplantation display a wide application prospect in the field of vascular diseases therapy such as ischemic disease of heart head blood-vessel and wound healing (Marsboom and Janssens, 2008; Parolini et al., 2009 ), which has opened up a new field of cell therapy. But on account of the difference between sample source and separation methods, EPCs are gained little. So, new isolation and cultivation method of EPC is needed urgently.
The endothelial cells play an important role in maintaining the stability of vascular intima, the damage of endothelial cells will cause the diseases of the cardiovascular system (George et al., 2004) . Scientists have been looking for the method to repair vascular endothelium via amplification of endothelial progenitor cells in vitro (Schmeisser et al., 2001 ; Gao et al., 2008; You et al., 2008) . The discovery of EPC provides premise to achieve this desire. Asahara isolated the bone marrow sources of cells that CD34 and KDR positive from peripheral blood, which is called EPC now. later (Asahara et al., 1997; Kawamura et al., 2006) , scientists also isolated EPC from umbilical cord blood, liver, marrow, arterial outer membrane and fat tissue (Eggermann et al., 2003; Bonello et al., 2006) . They all can directionally home to the ischemic area and differentiate into mature endothelial cells with delayed high proliferation potential, not only can they participate in the embryonic development of angiogenesis, but also promote restoration of the damaged endothelial capillaries (Peichev et al., 2000; De Falco et al., 2009 ), apply to endangered species resources conservation. This research will explore the methods of isolation and culture, characterization and induced differentiation of EPC from bovine bone marrow.
MATERIALS AND METHODS
Ethical statement: All animal bodies are treated in accordance with NIH and USDA guidelines for the use of animals in research and all experimental procedures involving bovine are conducted in accordance with the protocols and guidelines for agricultural animal research codified by the Committee for Ethics of Beijing, China.
Experimental reagents: DMEM/F12 (Gibco, USA), fetal bovine serum (Biochrom, Germany) Percoll lymphocyte separating (Pharmasha), Trypsin 1: 250 (Amresco), VEGF, bFGF, IGF-1, PDGF-BB (Invitrogen, USA), rabbit anti chicken CD34, flk and CD133 polyclonal antibody (MBL, Japan), EDTA, FITC conjugated goat anti rabbit secondary antibody IgG (Zhongshan Golden Bridge, China).
Isolation and culture of bovine EPCs: Bovine fetus is putted to execution and soaked with 75% ethyl alcohol for disinfection immediately. Thighbone and shinbone are isolated from body, marrow cavities are washed with 3 mL PBS. Beating together of the liquid and adding up to 3 mL stem cell separation fluid of 1.077 gm/mL density 1500 r/min. Afterwards drawing monocyte present white clouds at the interface. Washing with PBS for 2 times. Finally aseptic operation is needed to pay attention all the whole process.
Cells are inoculated in terms of 5.0x10 6 /mL density in DMEM/F12 with 10% FBS and VEGF 10 ng/mL, cultured under 37°C, 5% CO2, saturated humidity. Changing medium after 1 day of inoculation, then changing medium every 2 days. Cells can be passaged when going to 70-80% healing.
Estimation of cell viability: EPC viability before and after cryopreservation is detected using the Trypan Blue Solution exclusion test (Liu et al., 2010) . Collecting cells when cell confluence degrees reach 80-90%, making into cell suspension of 2.0×10 6 density. Mixing 100 μL cell suspension and 100 μL Trypan Blue Solution, calculating total number of cells and cell number does not shade with blood count plate. Three lines are drawed after the data sorting table. Dil-ac-LDL and FITC-UEA-l uptake by EPCs: EPC of passages 5 which go to 60-70% healing is selected. Washed thrice using PBS, then incubated in media containing 12 μg/mL Dil-ac-LDL for 4 h at 37°C, 5% CO2. Then cells are washed thrice more, fixed with 2% paraformaldehyde, and incubated for 1h with FITC-UEA-1 of 10 μg/mL concentration at room temperature. Images are got from laser scanning confocal microscope.
Endothelial differentiation: EPC attaining 60-70% confluence and in good growth status are selected. There are two groups divided. EPC of the experimental group is cultured with endotheliocyte medium containing 30 ng/mL VEGF, while EPC of control group remain in complete medium. Medium are refreshed every three days and immunofluorescence histochemical detection are carried out 20 days later, endothelial cells surface marker calpain, CD31 and PCDH12 are detected. EPC of control group used as a comparation.
Smooth muscle cell differentiation: EPC attaining 60-70% confluence and in good growth status are selected. There are two groups divided. Cells of the induced group is incubated in endotheliocyte medium containing 10 ng/mL PDGF-BB, while control cells remain in complete medium. The medium are refreshed every three days. Immunofluorescence histochemical detection are carried out 21 days later, smooth muscle cells marker SM-MHC and α-actin are detected. EPC of control group is used as a comparation.
RESULTS

EPCs morphological observation:
Morphological feature is one of the important characters of cells.The isolated EPC exactly adhered are smaller and irregularly shaped ( Figure 1A) . The cells proliferate quickly within 48 h with blood island structure and cell clusters begin to shape and display fusiform, triangular and irregular shapes. Cells connect fore and aft, a linear structure form. A small amount of cells connect into the structure of the blood sample after 4 days culture. Then EPCs are passaged and we find that they develop fibrosis gradually ( Figure 1C) . The cells attaining 70-80% confluence can be passaged,the average passage time is 4-6 days, and the cells can be cultured up to P10 at most (Figure 1) . Upon reaching P10, most cells display features representatively of senescence such as blebbing and karyopyknosis.
Estimation of cell viability:
The cells begin to adhere at 24 h after resuscitation, grow in good condition and passage normally as former. No significant differences have been found between cells before and after cryopreservation ( Table 1) . Immunofluorescence: EPC specific markers CD133, CD34 and flk are detected and images are captured by LSCM. We found that the cells expressed the three specific markers finally (Figure 2 ).
Karyotyping analysis:
We find that bovine diploid chromosome is 2n=60. It is a total of 29 pairs of chromosomes and 1 on the sex chromosomes. 
Dil-ac-LDL and FITC-UEA-l uptake by EPCs
Endothelial differentiation of the EPCs:
The capacity of bovine EPC to differentiate into endothelial cells is tested and then detected by subsequent morphological and phenotypic analysis. Cell morphology change from spindle to round or irregularly shaped after induction with VEGF for ten days. Immunofluorescence detection has been carried out after 20 days of induction to confirm that differentiation has occurred with the expression of 
Smooth muscle cell differentiation of the EPCs:
The ability of bovine EPC to differentiate into smooth muscle cells are also tested and then detected by subsequent morphological and phenotypic analysis. The cell morphology is changed at seven days after induction with becoming longer and forming structures typical of muscle cells. They express SM-MHC and α-actin which are specific markers for smooth muscle cells and detected by imunofluorescence ( Figure 5 ). Asahara et al. (1997) 
DISCUSSION
CONCLUSION
In short, this study explores an optimized method for the isolation and culture of bovine EPCs cells. We gained that express specific surface markers CD133, CD34 and flk of EPC by immunofluorescence on LSCM. Karyotyping analysis confirms that these cells come from bovine. Cell cryopreservation has little effects on bovine EPCs, which contribute to genetic resources conservation and reuse. We also induce bovine EPCs to differentiate into endothelial and smooth muscle cells, which supports the bovine EPCs multipotency potential in vitro. This study not only provides technological means for the establishment of a bovine EPC line, but also suggests a new method to preserve the valuable genetic resources of bovine, which provide a seed resource for clinical application in the future.
